[{"id":"0cb4320c-b227-4548-aa85-16ac4e5862f5","acronym":"","url":"https://clinicaltrials.gov/study/NCT03374943","created_at":"2021-01-19T08:29:44.647Z","updated_at":"2024-07-02T16:36:21.492Z","phase":"Phase 1","brief_title":"A Trial of KB004 in Patients With Glioblastoma","source_id_and_acronym":"NCT03374943","lead_sponsor":"Olivia Newton-John Cancer Research Institute","biomarkers":" EPHA3","pipe":"","alterations":" ","tags":["EPHA3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ifabotuzumab (KB004)"],"overall_status":"Completed","enrollment":" Enrollment 12","initiation":"Initiation: 12/05/2017","start_date":" 12/05/2017","primary_txt":" Primary completion: 01/25/2021","primary_completion_date":" 01/25/2021","study_txt":" Completion: 09/22/2021","study_completion_date":" 09/22/2021","last_update_posted":"2021-11-04"}]